Mooradian A D
Department of Internal Medicine, Saint Louis University School of Medicine, MO 63110, USA.
Growth Horm IGF Res. 2001 Jun;11 Suppl A:S79-83. doi: 10.1016/s1096-6374(01)80013-7.
Obesity is a growing public health problem worldwide. It is a particularly common problem among individuals with type 2 diabetes mellitus. The magnitude of obesity, the central location of fat, and a history of weight gain are independent risks for developing diabetes mellitus. Potential factors implicated in the pathogenesis of diabetes mellitus in obese patients include increased plasma free fatty acid concentrations, increased production of cytokines, increased leptin levels, and increased levels of a recently discovered protein called resistin. Epidemiological and interventional studies suggest that even modest loss of body weight, either by changes in lifestyle or pharmacological means is associated with significant amelioration of insulin resistance and improvement in diabetes mellitus control. Treatment of obesity is an important therapeutic goal in the management of patients with type 2 diabetes mellitus.
肥胖是全球日益严重的公共卫生问题。在2型糖尿病患者中,这是一个尤为常见的问题。肥胖程度、脂肪的中心分布位置以及体重增加史都是患糖尿病的独立风险因素。肥胖患者糖尿病发病机制中涉及的潜在因素包括血浆游离脂肪酸浓度升高、细胞因子产生增加、瘦素水平升高以及一种最近发现的名为抵抗素的蛋白质水平升高。流行病学和干预性研究表明,即使通过生活方式改变或药物手段实现适度体重减轻,也与胰岛素抵抗的显著改善以及糖尿病控制的改善相关。治疗肥胖是2型糖尿病患者管理中的一个重要治疗目标。